Remodelling Signal Pathways in Prostate Cancer - A New Target for Cancer Therapeutics

Prostate cancer mutations targeting PI3K signaling are greatly influenced by PLEKHS1, a protein, enhances cancer drug therapy efficiency.

Related Keywords

United Kingdom ,Babraham ,Cambridgeshire , ,Babraham Institute ,Signaling Mechanism ,Prostate Cancer The ,Prostate Cancer ,I3k Signaling ,Lekhs1 Protein ,Prostate Tumor ,Growth ,Ten Enzyme ,